Analyst Consensus ?
ConsensusBuy84 ratings
Bullish5565.5%
Neutral2529.7%
Bearish44.8%
1 unmapped firm rating excluded from the percentages.
Oracle Corporation · ORCL · FY2026 Q4 · Calendar Q2 2026
Oracle Q4 FY26: Revenue Up 21%, RPO Hits $638B, but $70B CapEx Plan Pressures Shares
Oracle closed FY2026 with a record fourth quarter, posting $19.2B in revenue (up 21% YoY) and beating EPS estimates by 7.7%. The quarter was defined by explosive AI infrastructure demand: cloud infrastructure grew 93%, RPO surged 363% to $638B, and the company signed $67B in new AI contracts at 97.5% GPU utilization. Management raised FY27 guidance to approximately 34% revenue growth and $8.05 non-GAAP EPS. However, the capital intensity required to deliver on this backlog is unprecedented: a $70B net CapEx plan, only partially offset by $20-25B in customer pre-payments. The market reacted sharply negatively, with the stock falling 8.5% on the next session and drifting 28.5% lower subsequently, suggesting investors are questioning whether the margin profile and cash-flow generation of this AI infrastructure ramp will justify the massive capital outlay.
Reported After market closeNYSETechnology
$345.57B market cap
100quality score
Company context
Snapshot as of publicationOracle Corporation, a global technology giant, provides a comprehensive suite of enterprise information technology solutions worldwide. A core part of its portfolio comprises cloud-based software-as-a-service (SaaS) applications, including the Oracle Fusion Cloud suite covering enterprise resource planning (ERP), enterprise performance management (EPM), supply chain and manufacturing management (SCM), and human capital management (HCM). This also extends to specialized offerings like Oracle Advertising, the NetSuite application suite, and Oracle Fusion solutions for Sales, Service, and Marketing. Beyond these, Oracle develops cloud solutions tailored for various specific industries, alongside traditional application licenses and comprehensive license support services. Furthermore, the company's robust cloud and licensing business is underpinned by its infrastructure technologies.…
Earnings scorecard
Reported versus consensus
Reported EPS
$2.11
Consensus $2
EPS surprise
+7.7%
Reported versus consensus
Reported revenue
$19.18B
Consensus $19.10B
Revenue surprise
+0.4%
Reported versus consensus
Earnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$142.45Previous close
$80Low
$242.92Average
$400High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Aug 25, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Buy | Maintain | Aug 6, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jun 11, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 11, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Jun 11, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Jun 11, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jun 11, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jun 11, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jun 11, 2026 |
| DA Davidson | Buy | Buy | Maintain | Jun 11, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jun 11, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jun 11, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 11, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 9, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jun 8, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jun 8, 2026 |
| BTIG | Buy | Buy | Maintain | Jun 5, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 4, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 23, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 16, 2026 |
| Stifel | Buy | Buy | Maintain | Mar 11, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | Mar 11, 2026 |
| Baird | Outperform | Outperform | Maintain | Mar 10, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Mar 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Mar 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Feb 5, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Dec 12, 2025 |
| Keybanc | Overweight | Overweight | Maintain | Dec 11, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 17, 2025 |
| Berenberg | Hold | Hold | Maintain | Sep 15, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Sep 10, 2025 |
| Melius Research | Buy | Buy | Maintain | Sep 10, 2025 |
| WestPark Capital | Buy | Buy | Maintain | Jun 12, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 11, 2025 |
| Argus Research | Buy | Buy | Maintain | Jun 18, 2024 |
| HSBC | Buy | Buy | Maintain | Mar 13, 2024 |
| William Blair | Outperform | Market Perform | Upgrade | Mar 12, 2024 |
| Erste Group | Hold | Buy | Downgrade | Dec 22, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Nov 13, 2023 |
| DZ Bank | Buy | Hold | Upgrade | Sep 14, 2023 |
| Monness, Crespi, Hardt | Neutral | Buy | Downgrade | Sep 12, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Mar 15, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Dec 13, 2022 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Jun 29, 2022 |
| Daiwa Capital | Neutral | Neutral | Maintain | Jun 27, 2022 |
| Societe Generale | Hold | Hold | Maintain | Dec 10, 2021 |
| Wells Fargo | Overweight | Overweight | Maintain | Mar 11, 2021 |
| Cleveland Research | Neutral | Buy | Downgrade | Dec 8, 2020 |
| Raymond James | Outperform | Outperform | Maintain | Mar 13, 2020 |
| Nomura | Reduce | Reduce | Maintain | Dec 16, 2019 |
| Macquarie | Neutral | Outperform | Downgrade | Jun 18, 2019 |
| Atlantic Equities | Underweight | Underweight | Maintain | Jan 9, 2019 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 26, 2018 |
| Needham | Hold | Hold | Maintain | Oct 23, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Sep 18, 2018 |
| Bank of America | Neutral | Neutral | Maintain | Sep 18, 2018 |
| Rosenblatt | Neutral | Buy | Downgrade | Jun 20, 2018 |
| Monness Crespi Hardt | Neutral | Neutral | Maintain | Apr 11, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 4, 2017 |
| Moffett Nathanson | Buy | Buy | Maintain | Sep 6, 2017 |
| Argus | Buy | Hold | Upgrade | Jun 23, 2017 |
| Benchmark | Buy | Buy | Maintain | Apr 27, 2017 |
| OTR Global | Mixed | Positive | Downgrade | Sep 8, 2016 |
| BTIG Research | Buy | Buy | Maintain | Jul 14, 2016 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jun 17, 2016 |
| Wunderlich | Hold | Buy | Downgrade | Jun 17, 2016 |
| Pacific Crest | Sector Weight | Maintain | Jun 17, 2016 | |
| Canaccord Genuity | Buy | Buy | Maintain | Mar 16, 2016 |
| FBR Capital | Market Perform | Outperform | Downgrade | Nov 5, 2015 |
| SunTrust Robinson Humphrey | Buy | Neutral | Upgrade | Sep 16, 2015 |
| Tigress Financial | Neutral | Buy | Downgrade | Oct 22, 2014 |
| D.A. Davidson | Buy | Neutral | Upgrade | Oct 6, 2014 |
| MKM Partners | Neutral | Neutral | Maintain | Sep 10, 2014 |
| Maxim Group | Buy | Buy | Maintain | Jun 4, 2014 |
| JG Capital | Underweight | Neutral | Downgrade | Apr 15, 2014 |
| Argus Capital | Hold | Buy | Downgrade | Mar 20, 2014 |
| Susquehanna | Positive | Positive | Maintain | Mar 3, 2014 |
| Sterne Agee | Neutral | Neutral | Maintain | Feb 4, 2014 |
| LBBW Research | Buy | Hold | Upgrade | Dec 20, 2013 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Mar 21, 2013 |
| CLSA | Underperform | Outperform | Downgrade | Mar 21, 2013 |
| Davenport | Buy | Neutral | Upgrade | Jan 11, 2013 |
| Janney Capital | Buy | Buy | Maintain | Dec 14, 2012 |
| Longbow Research | Buy | Buy | Maintain | Aug 20, 2012 |
| Morgan Keegan | Outperform | Outperform | Maintain | Mar 21, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $142.45. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Mark Moerdler | $95 | $148.91 | -33.3% | Aug 12, 2026 |
| UBS | Karl Keirstead | $245 | $144.36 | +72.0% | Aug 6, 2026 |
| CLSA | Bhavtosh Vajpayee | $145 | $126.48 | +1.8% | Jul 20, 2026 |
| D.A. Davidson | Analyst unavailable | $225 | $180.22 | +58.0% | Jun 11, 2026 |
| Wedbush | Analyst unavailable | $240 | $201.26 | +68.5% | Jun 11, 2026 |
| BMO Capital | Keith Bachman | $220 | $201.26 | +54.4% | Jun 11, 2026 |
| Bernstein | Mark Moerdler | $325 | $201.26 | +128.2% | Jun 11, 2026 |
| Piper Sandler | Analyst unavailable | $225 | $201.26 | +58.0% | Jun 11, 2026 |
| Scotiabank | Pat Colville | $241 | $201.26 | +69.2% | Jun 11, 2026 |
| Wolfe Research | Alex Zukin | $225 | $201.26 | +58.0% | Jun 11, 2026 |
| Barclays | Raimo Lenschow | $250 | $201.26 | +75.5% | Jun 11, 2026 |
| MoffettNathanson | Analyst unavailable | $325 | $201.26 | +128.2% | Jun 11, 2026 |
| Oppenheimer | Brian Schwartz | $275 | $213.41 | +93.1% | Jun 8, 2026 |
| Evercore ISI | Kirk Materne | $245 | $213.41 | +72.0% | Jun 8, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $284 | $220.15 | +99.4% | Jun 5, 2026 |
| RBC Capital | Analyst unavailable | $190 | $236.34 | +33.4% | Jun 4, 2026 |
| Mizuho Securities | Siti Panigrahi | $320 | $244.54 | +124.6% | Jun 3, 2026 |
| UBS | Karl Keirstead | $285 | $239.41 | +100.1% | Jun 2, 2026 |
| Scotiabank | Pat Colville | $290 | $248.07 | +103.6% | Jun 2, 2026 |
| Wedbush | Analyst unavailable | $275 | $187.74 | +93.1% | May 13, 2026 |
| Oppenheimer | Brian Schwartz | $235 | $193.83 | +65.0% | May 12, 2026 |
| Arete Research | Analyst unavailable | $255 | $193.99 | +79.0% | May 7, 2026 |
| Wedbush | Analyst unavailable | $225 | $176.28 | +58.0% | Apr 24, 2026 |
| Morgan Stanley | Keith Weiss | $207 | $175.66 | +45.3% | Apr 23, 2026 |
| Deutsche Bank | Brad Zelnick | $300 | $162.32 | +110.6% | Mar 11, 2026 |
| RBC Capital | Rishi Jaluria | $160 | $163.12 | +12.3% | Mar 11, 2026 |
| Stifel Nicolaus | Brad Reback | $220 | $163.12 | +54.4% | Mar 11, 2026 |
| Scotiabank | Analyst unavailable | $215 | $151.56 | +50.9% | Mar 9, 2026 |
| Cantor Fitzgerald | Thomas Blakey | $229 | $151.56 | +60.8% | Mar 9, 2026 |
| Barclays | Raimo Lenschow | $230 | $151.56 | +61.5% | Mar 9, 2026 |
| Jefferies | Brent Thill | $320 | $154.67 | +124.6% | Mar 5, 2026 |
| Melius Research | Ben Reitzes | $160 | $156.56 | +12.3% | Feb 9, 2026 |
| Bernstein | Analyst unavailable | $313 | $142.78 | +119.7% | Feb 9, 2026 |
| BMO Capital | Analyst unavailable | $205 | $147.05 | +43.9% | Feb 4, 2026 |
| Scotiabank | Analyst unavailable | $220 | $155.02 | +54.4% | Feb 3, 2026 |
| Piper Sandler | Analyst unavailable | $240 | $160.13 | +68.5% | Feb 2, 2026 |
| Morgan Stanley | Analyst unavailable | $213 | $178.16 | +49.5% | Jan 23, 2026 |
| Goldman Sachs | Analyst unavailable | $240 | $198.52 | +68.5% | Jan 11, 2026 |
| UBS | Analyst unavailable | $280 | $196.11 | +96.6% | Jan 5, 2026 |
| RBC Capital | Rishi Jaluria | $195 | $195.71 | +36.9% | Jan 5, 2026 |
| Mizuho Securities | Siti Panigrahi | $400 | $189.59 | +180.8% | Dec 15, 2025 |
| Goldman Sachs | Kash Rangan | $220 | $198.64 | +54.4% | Dec 12, 2025 |
| UBS | Analyst unavailable | $325 | $192.66 | +128.2% | Dec 11, 2025 |
| KeyBanc | Jackson Ader | $300 | $192.13 | +110.6% | Dec 11, 2025 |
| D.A. Davidson | Analyst unavailable | $180 | $189.94 | +26.4% | Dec 11, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $320 | $189.62 | +124.6% | Dec 11, 2025 |
| RBC Capital | Analyst unavailable | $250 | $223.3 | +75.5% | Dec 11, 2025 |
| Stifel Nicolaus | Brad Reback | $275 | $223.3 | +93.1% | Dec 11, 2025 |
| Barclays | Raimo Lenschow | $310 | $223.3 | +117.6% | Dec 11, 2025 |
| BMO Capital | Analyst unavailable | $270 | $223.3 | +89.5% | Dec 11, 2025 |
| Scotiabank | Pat Colville | $260 | $193.21 | +82.5% | Dec 11, 2025 |
| Bernstein | Analyst unavailable | $339 | $223.3 | +138.0% | Dec 11, 2025 |
| Piper Sandler | Analyst unavailable | $290 | $223.3 | +103.6% | Dec 11, 2025 |
| Barclays | Analyst unavailable | $330 | $217.58 | +131.7% | Dec 8, 2025 |
| RBC Capital | Rishi Jaluria | $310 | $217.17 | +117.6% | Dec 5, 2025 |
| Wells Fargo | Analyst unavailable | $280 | $201.1 | +96.6% | Dec 3, 2025 |
| HSBC | Stephen Bersey | $382 | $205.21 | +168.2% | Nov 26, 2025 |
| Deutsche Bank | Brad Zelnick | $375 | $205.26 | +163.3% | Nov 26, 2025 |
| D.A. Davidson | Gil Luria | $200 | $199.88 | +40.4% | Nov 25, 2025 |
| Robert W. Baird | Analyst unavailable | $315 | $220.49 | +121.1% | Nov 18, 2025 |
| Goldman Sachs | Analyst unavailable | $320 | $288.95 | +124.6% | Oct 20, 2025 |
| Scotiabank | Patrick Colville | $360 | $291.23 | +152.7% | Oct 17, 2025 |
| Evercore ISI | Analyst unavailable | $385 | $313 | +170.3% | Oct 17, 2025 |
| Stephens | Brett Huff | $331 | $313 | +132.4% | Oct 17, 2025 |
| Piper Sandler | Brent Bracelin | $380 | $313 | +166.8% | Oct 17, 2025 |
| Guggenheim | John DiFucci | $400 | $313 | +180.8% | Oct 17, 2025 |
| UBS | Karl Keirstead | $380 | $313 | +166.8% | Oct 17, 2025 |
| Barclays | Analyst unavailable | $400 | $313 | +180.8% | Oct 17, 2025 |
| Jefferies | Analyst unavailable | $400 | $313 | +180.8% | Oct 17, 2025 |
| BMO Capital | Keith Bachman | $355 | $292.96 | +149.2% | Oct 13, 2025 |
| Evercore ISI | Kirk Materne | $350 | $296.96 | +145.7% | Oct 10, 2025 |
| Robert W. Baird | Analyst unavailable | $365 | $288.63 | +156.2% | Oct 8, 2025 |
| UBS | Analyst unavailable | $364 | $291.41 | +155.5% | Sep 26, 2025 |
| Redburn Partners | Alex Haissl | $175 | $295.08 | +22.9% | Sep 25, 2025 |
| BNP Paribas | Analyst unavailable | $377 | $328.33 | +164.7% | Sep 10, 2025 |
| Scotiabank | Patrick Colville | $350 | $328.33 | +145.7% | Sep 10, 2025 |
| UBS | Analyst unavailable | $300 | $328.33 | +110.6% | Sep 10, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $400 | $328.33 | +180.8% | Sep 10, 2025 |
| Cowen & Co. | Analyst unavailable | $375 | $328.33 | +163.3% | Sep 10, 2025 |
| UBS | Karl Keirstead | $360 | $328.33 | +152.7% | Sep 10, 2025 |
| Mizuho Securities | Analyst unavailable | $350 | $328.33 | +145.7% | Sep 10, 2025 |
| BMO Capital | Analyst unavailable | $345 | $328.33 | +142.2% | Sep 10, 2025 |
| Guggenheim | John DiFucci | $375 | $337.28 | +163.3% | Sep 10, 2025 |
| Evercore ISI | Analyst unavailable | $340 | $328.33 | +138.7% | Sep 10, 2025 |
| Jefferies | Analyst unavailable | $360 | $328.33 | +152.7% | Sep 10, 2025 |
| Stifel Nicolaus | Analyst unavailable | $350 | $328.33 | +145.7% | Sep 10, 2025 |
| Piper Sandler | Analyst unavailable | $330 | $328.33 | +131.7% | Sep 10, 2025 |
| Melius Research | Analyst unavailable | $370 | $328.33 | +159.7% | Sep 10, 2025 |
| JMP Securities | Patrick Walravens | $342 | $337.12 | +140.1% | Sep 10, 2025 |
| BMO Capital | Keith Bachman | $275 | $241.51 | +93.1% | Sep 9, 2025 |
| Barclays | Raimo Lenschow | $281 | $238.48 | +97.3% | Sep 8, 2025 |
| UBS | Karl Keirstead | $250 | $210.72 | +75.5% | Jun 25, 2025 |
| Guggenheim | John DiFucci | $250 | $210.87 | +75.5% | Jun 18, 2025 |
| JMP Securities | Patrick Walravens | $240 | $199.86 | +68.5% | Jun 12, 2025 |
| Loop Capital Markets | Mark Murphy | $135 | $177.48 | -5.2% | Jun 10, 2025 |
| Morgan Stanley | Keith Weiss | $175 | $177.15 | +22.9% | Jun 9, 2025 |
| Morgan Stanley | Keith Weiss | $160 | $129.76 | +12.3% | Apr 16, 2025 |
| D.A. Davidson | Gil Luria | $140 | $134.64 | -1.7% | Apr 14, 2025 |
| Stephens | Analyst unavailable | $167 | $149.45 | +17.2% | Mar 18, 2025 |
| RBC Capital | Rishi Jaluria | $145 | $144.18 | +1.8% | Mar 11, 2025 |
| Piper Sandler | Analyst unavailable | $190 | $144.18 | +33.4% | Mar 11, 2025 |
| Barclays | Raimo Lenschow | $202 | $144.18 | +41.8% | Mar 11, 2025 |
| Monness | Brian White | $130 | $167.2 | -8.7% | Dec 20, 2024 |
| Argus Research | Joseph Bonner | $200 | $178.58 | +40.4% | Dec 11, 2024 |
| UBS | Karl Keirstead | $210 | $177.74 | +47.4% | Dec 10, 2024 |
| Guggenheim | John DiFucci | $220 | $187.52 | +54.4% | Dec 5, 2024 |
| RBC Capital | Rishi Jaluria | $165 | $175.31 | +15.8% | Oct 23, 2024 |
| HSBC | Stephen Bersey | $210 | $170.11 | +47.4% | Sep 16, 2024 |
| Jefferies | Brent Thill | $190 | $162.03 | +33.4% | Sep 15, 2024 |
| Piper Sandler | Brent Bracelin | $185 | $164.56 | +29.9% | Sep 13, 2024 |
| Citigroup | Tyler Radke | $157 | $161.38 | +10.2% | Sep 13, 2024 |
| Deutsche Bank | Brad Zelnick | $200 | $161.38 | +40.4% | Sep 13, 2024 |
| Evercore ISI | Kirk Materne | $190 | $161.38 | +33.4% | Sep 13, 2024 |
| KeyBanc | Jackson Ader | $190 | $161.38 | +33.4% | Sep 13, 2024 |
| UBS | Karl Keirstead | $200 | $161.38 | +40.4% | Sep 13, 2024 |
| JMP Securities | Patrick Walravens | $175 | $156.59 | +22.9% | Sep 10, 2024 |
| JMP Securities | Silvan Tuerkcan | $80 | $156.38 | -43.8% | Sep 10, 2024 |
| BMO Capital | Keith Bachman | $173 | $156.8 | +21.4% | Sep 10, 2024 |
| Piper Sandler | Brent Bracelin | $175 | $156.82 | +22.9% | Sep 10, 2024 |
| Stifel Nicolaus | Brad Reback | $155 | $156.48 | +8.8% | Sep 10, 2024 |
| Melius Research | Ben Reitzes | $155 | $156.64 | +8.8% | Sep 10, 2024 |
| Mizuho Securities | Siti Panigrahi | $185 | $155.89 | +29.9% | Sep 10, 2024 |
| KeyBanc | Jackson Ader | $175 | $156.52 | +22.9% | Sep 10, 2024 |
| BMO Capital | Keith Bachman | $160 | $142.34 | +12.3% | Sep 9, 2024 |
| Bernstein | Mark Moerdler | $171 | $141.55 | +20.0% | Sep 3, 2024 |
| Jefferies | Brent Thill | $150 | $140.68 | +5.3% | Jul 9, 2024 |
| Argus Research | Joseph Bonner | $159 | $141.31 | +11.6% | Jun 18, 2024 |
| Mizuho Securities | Siti Panigrahi | $170 | $139.33 | +19.3% | Jun 17, 2024 |
| Piper Sandler | Brent Bracelin | $150 | $123.88 | +5.3% | Jun 12, 2024 |
| Morgan Stanley | Keith Weiss | $125 | $123.88 | -12.2% | Jun 12, 2024 |
| Barclays | Raimo Lenschow | $160 | $139.64 | +12.3% | Jun 12, 2024 |
| Stifel Nicolaus | Brad Reback | $135 | $123.88 | -5.2% | Jun 12, 2024 |
| CFRA | Angelo Zino | $150 | $123.88 | +5.3% | Jun 12, 2024 |
| Deutsche Bank | Brad Zelnick | $150 | $123.88 | +5.3% | Jun 12, 2024 |
| Evercore ISI | Kirk Materne | $160 | $123.88 | +12.3% | Jun 12, 2024 |
| D.A. Davidson | Gil Luria | $105 | $123.88 | -26.3% | Jun 12, 2024 |
| KeyBanc | Jackson Ader | $165 | $139.15 | +15.8% | Jun 12, 2024 |
| Morgan Stanley | Keith Weiss | $155 | $124.5 | +8.8% | Jun 10, 2024 |
| Barclays | Raimo Lenschow | $147 | $124.5 | +3.2% | Jun 10, 2024 |
| BMO Capital | Keith Bachman | $142 | $123.68 | -0.3% | Jun 6, 2024 |
| UBS | Karl Keirstead | $150 | $114.53 | +5.3% | Apr 22, 2024 |
| KeyBanc | Jackson Ader | $150 | $129.24 | +5.3% | Mar 20, 2024 |
| Argus Research | Joseph Bonner | $145 | $125.53 | +1.8% | Mar 14, 2024 |
| HSBC | Stephen Bersey | $152 | $125.52 | +6.7% | Mar 13, 2024 |
| Piper Sandler | Brent Bracelin | $140 | $127.54 | -1.7% | Mar 12, 2024 |
| CFRA | Angelo Zino | $142 | $127.54 | -0.3% | Mar 12, 2024 |
| Stifel Nicolaus | Brad Reback | $120 | $127.54 | -15.8% | Mar 12, 2024 |
| Mizuho Securities | Siti Panigrahi | $160 | $127.54 | +12.3% | Mar 12, 2024 |
| Morgan Stanley | Keith Weiss | $107 | $112.87 | -24.9% | Dec 8, 2023 |
| Mizuho Securities | Siti Panigrahi | $150 | $112.3 | +5.3% | Dec 7, 2023 |
| Guggenheim | John DiFucci | $150 | $109.03 | +5.3% | Sep 22, 2023 |
| Jefferies | Brent Thill | $145 | $126.32 | +1.8% | Sep 11, 2023 |
| UBS | Karl Keirstead | $140 | $116.84 | -1.7% | Aug 28, 2023 |
| Morgan Stanley | Keith Weiss | $105 | $118.03 | -26.3% | Jun 13, 2023 |
| Goldman Sachs | Kash Rangan | $120 | $116.43 | -15.8% | Jun 13, 2023 |
| Wolfe Research | Alex Zukin | $130 | $109.85 | -8.7% | Jun 12, 2023 |
| Piper Sandler | Brent Bracelin | $130 | $107.48 | -8.7% | Jun 9, 2023 |
| Mizuho Securities | Siti Panigrahi | $116 | $83.87 | -18.6% | Mar 10, 2023 |
| Piper Sandler | Analyst unavailable | $104 | $85.66 | -27.0% | Jan 9, 2023 |
| Jefferies | Analyst unavailable | $105 | $84.62 | -26.3% | Jan 5, 2023 |
| Guggenheim | John DiFucci | $115 | $82.26 | -19.3% | Dec 13, 2022 |
| Cowen & Co. | Analyst unavailable | $96 | $83.01 | -32.6% | Dec 13, 2022 |
| Piper Sandler | Analyst unavailable | $85 | $81.28 | -40.3% | Dec 13, 2022 |
| Barclays | Analyst unavailable | $81 | $83.35 | -43.1% | Dec 5, 2022 |
| Morgan Stanley | Keith Weiss | $90 | $77.2 | -36.8% | Sep 13, 2022 |
| Jefferies | Brent Thill | $85 | $77.08 | -40.3% | Sep 13, 2022 |
| Piper Sandler | Brent Bracelin | $70 | $77.08 | -50.9% | Sep 13, 2022 |
| Evercore ISI | Kirk Materne | $87 | $76.04 | -38.9% | Sep 13, 2022 |
| BMO Capital | Keith Bachman | $90 | $76.04 | -36.8% | Sep 13, 2022 |
| Credit Suisse | Phil Winslow's | $115 | $73.83 | -19.3% | Jul 21, 2022 |
| BNP Paribas | Stefan Slowinski | $90 | $70.87 | -36.8% | Jul 4, 2022 |
| Stifel Nicolaus | Brad Reback | $72 | $64.05 | -49.5% | Jun 14, 2022 |
| Jefferies | Brent Thill | $80 | $70.72 | -43.8% | Jun 14, 2022 |
| Citigroup | Tyler Radke | $75 | $64.05 | -47.3% | Jun 13, 2022 |
| Evercore ISI | Kirk Materne | $88 | $67.14 | -38.2% | Jun 10, 2022 |
| Cowen & Co. | Derrick Wood | $98 | $69.22 | -31.2% | Jun 9, 2022 |
| Barclays | Raimo Lenschow | $82 | $72.69 | -42.4% | Jun 7, 2022 |
| Morgan Stanley | Keith Weiss | $88 | $73.07 | -38.2% | Jun 6, 2022 |
| Monness | Brian White | $126 | $72.97 | -11.5% | Jun 6, 2022 |
| Jefferies | Brent Thill | $75 | $69.94 | -47.3% | May 23, 2022 |
| BMO Capital | Keith Bachman | $92 | $77.52 | -35.4% | Mar 11, 2022 |
| Bank of America Securities | Bradley Sills | $90 | $77.52 | -36.8% | Mar 11, 2022 |
| Societe Generale | Richard Nguyen | $98 | $77.52 | -31.2% | Mar 11, 2022 |
| Wolfe Research | Alex Zukin | $83 | $77.82 | -41.7% | Mar 11, 2022 |
| Evercore ISI | Kirk Materne | $88 | $77.52 | -38.2% | Mar 11, 2022 |
| Jefferies | Brent Thill | $80 | $75.8 | -43.8% | Mar 9, 2022 |
| Cowen & Co. | Derrick Wood | $100 | $75.8 | -29.8% | Mar 9, 2022 |
| UBS | Karl Keirstead | $75 | $73.04 | -47.3% | Mar 8, 2022 |
| Deutsche Bank | Brad Zelnick | $110 | $73.04 | -22.8% | Mar 8, 2022 |
| DZ BANK AG | Ingo Wermann | $105 | $102.86 | -26.3% | Dec 15, 2021 |
| Citigroup | Tyler Radke | $100 | $100.12 | -29.8% | Dec 13, 2021 |
| Morgan Stanley | Keith Weiss | $87 | $85.22 | -38.9% | Sep 20, 2021 |
| Goldman Sachs | Kash Rangan | $66 | $85.44 | -53.7% | Sep 14, 2021 |
Track every rating change on ORCL the moment it posts. Free to start.
Start freeMarket reaction
event-close to next-session close
Stock move
-8.5%
Event window
SPY move
+1.7%
Same window
Abnormal move
-10.2%
Stock minus SPY
Volume
2.8×
Versus trailing sessions
Subsequent drift
-28.5%
Up to 20 sessions
ORCLSPY benchmark
Follow ORCL with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeTranscript intelligence
What changed
Oracle reported FY2026 Q4 revenue of $19.184B (up 21% YoY), beating the $19.101B consensus estimate by 0.4%. Non-GAAP EPS of $2.11 exceeded the $1.96 estimate by 7.7%. Cloud infrastructure revenue grew 93% YoY and cloud applications grew 10% YoY. The company signed $67B in new AI infrastructure contracts during the quarter, bringing bring-your-own-hardware contracts to $75B total. RPO surged 363% to $638B. GPU utilization reached 97.5%. Management raised FY27 guidance to ~34% revenue growth and $8.05 non-GAAP EPS, while announcing a $70B net CapEx program partially offset by $20-25B in customer pre-payments. New outcome-based and token-bundle pricing models were introduced, with token bundles reaching 33 customers in a limited rollout. Despite the beat and raised guidance, the stock fell 8.5% in the next session (abnormal move of -10.2% vs SPY +1.7%) and drifted 28.5% lower subsequently on volume 2.8x baseline.
Guidance delta
Management raised FY27 guidance to approximately 34% revenue growth and non-GAAP EPS of $8.05, an acceleration from the 21% YoY growth delivered in Q4 FY26. The prior quarter (Q3 FY26) also carried a raised guidance sentiment. The raised outlook is underpinned by the $638B RPO backlog and $67B in quarterly AI infrastructure contract signings, but the $70B net CapEx commitment marks a significant step-up in capital intensity compared to prior periods.
Key takeaways
- Q4 FY26 revenue of $19.2B grew 21% YoY, beating estimates; EPS of $2.11 beat by 7.7%.
- Cloud infrastructure revenue grew 93% YoY, driven by surging AI workload demand.
- RPO surged 363% to $638B, providing exceptional multi-year revenue visibility.
- $67B in new AI infrastructure contracts signed in the quarter; BYOH contracts now total $75B.
- GPU utilization at 97.5% indicates near-full capacity utilization.
- FY27 guidance raised to ~34% revenue growth and $8.05 non-GAAP EPS.
Management priorities
- Scaling AI infrastructure capacity with new data-center sites in Texas, New Mexico, Michigan, and Wisconsin.
- Rolling out AI functionality across the Oracle database and applications stack.
- Expanding token-bundle and outcome-based pricing models from limited rollout to broader customer base.
- Executing the $70B CapEx program while leveraging $20-25B in customer pre-payments to manage cash flow.
- Maintaining high GPU utilization and converting RPO into recognized revenue.
Sources
- Earnings call transcript and parsed analysis · 2026-06-10T23:25:01.756912+00:00
- FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
- Polygon adjusted daily market bars · 2026-07-28T09:22:48.929310+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-07-28T09:22:48.926532+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.